中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2017, Vol. 16 ›› Issue (05): 289-292.doi: 10.3969/j.issn.1671-4091.2017.05.001
Next Articles
Received:
Online:
Published:
Abstract: Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right heart failure and death if untreated. It is a common abnormality in patients with dialysis-dependent chronic kidney disease, especially those having arteriovenous fistula. With the increase of chronic kidney disease patients, the prevalence of severe PAH and the mortality of cardiac diseases are significantly increasing. Several factors cause the development and progression of PAH. Clinically, PAH should be identified and treated earlier to mitigate the susceptible factors and to prevent the development of PAH.
Key words: Pulmonary arterial hypertension (PAH), Hemodialysis, Pathogenesis, Therapy
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2017.05.001
https://www.cjbp.org.cn/EN/Y2017/V16/I05/289